A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides-Reference-Cited by-同舟云学术

A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides

Published:2020-12-16 Issue:2 Volume:178 Page:363-377
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Peric Mihaela¹²^ORCID,Pešić Dijana¹³,Alihodžić Sulejman¹³,Fajdetić Andrea¹³,Herreros Esperanza⁴⁵,Gamo Francisco Javier⁴,Angulo‐Barturen Iñigo⁴⁶,Jiménez‐Díaz María Belén⁴⁶,Ferrer‐Bazaga Santiago⁴,Martínez María S.⁴,Gargallo‐Viola Domingo⁴⁷,Mathis Amanda⁸⁹,Kessler Albane⁴,Banjanac Mihailo¹³,Padovan Jasna¹³,Bencetić Mihaljević Vlatka¹³,Munic Kos Vesna¹¹⁰,Bukvić Mirjana¹³,Eraković Haber Vesna¹³,Spaventi Radan¹¹¹

Affiliation:

1. GlaxoSmithKline Research Centre Zagreb Ltd. Zagreb Croatia

2. Center for Translational and Clinical Research, Department for Intercellular Communication University of Zagreb School of Medicine Zagreb Croatia

3. Fidelta Ltd. Zagreb Croatia

4. GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World Tres Cantos (Madrid) Spain

5. Medicines for Malaria Venture Geneva 15 Switzerland

6. The Art of Discovery Bizkaia Basque Country Spain

7. ABAC Therapeutics Barcelona Spain

8. GlaxoSmithKline Research Triangle Park North Carolina USA

9. BioCryst Pharmaceuticals Durham North Carolina USA

10. Department of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden

11. Triadelta Partners Ltd Zagreb Croatia